Synopsis
Motivation:
Goals:
Approach:
Results:
563-01-011
ISMRM Abstract
Subtype-Specific Locus Coeruleus Degeneration Across Parkinson’s Disease and Multiple System Atrophy on NM-MRI
Accepted
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
Log inReferences
1. Aarsland D, Batzu L, Halliday GM, et al. Parkinson disease-associated cognitive impairment. Nat Rev Dis Primer. 2021;7(1):47. doi:10.1038/s41572-021-00280-3 [doi]
2. Steinmetz JD, Seeher KM, Schiess N, et al. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 2024;23(4):344-381. doi:10.1016/S1474-4422(24)00038-3 [doi]
3. Su D, Cui Y, He C, et al. Projections for prevalence of Parkinson’s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021. BMJ. 2025;388:e080952. doi:10.1136/bmj-2024-080952 [doi]
4. Sulzer D, Cassidy C, Horga G, et al. Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson’s disease. Npj Park Dis. 2018;4(1):11. doi:10.1038/s41531-018-0047-3 [doi]
5. Trujillo P, Aumann MA, Claassen DO. Neuromelanin-sensitive MRI as a promising biomarker of catecholamine function. Brain. 2023;147(2):337-351. doi:10.1093/brain/awad300 [doi]
6. Goh YY, Saunders E, Pavey S, et al. Multiple system atrophy. Pract Neurol. Published online March 16, 2023. doi:10.1136/pn-2020-002797 [doi]
7. Wenning GK, Tison F, Ben Shlomo Y, Daniel SE, Quinn NP. Multiple system atrophy: A review of 203 pathologically proven cases. Mov Disord Off J Mov Disord Soc. 1997;12(2):133-147. doi:10.1002/mds.870120203 [doi]
8. Poe GR, Foote S, Eschenko O, et al. Locus coeruleus: a new look at the blue spot. Nat Rev Neurosci. 2020;21(11):644-659. doi:10.1038/s41583-020-0360-9 [doi]
9. Braak H, Del Tredici K, Rüb U, de Vos RAI, Jansen Steur ENH, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging. 2003;24(2):197-211. doi:10.1016/s0197-4580(02)00065-9 [doi]
10. Zarow C, Lyness SA, Mortimer JA, Chui HC. Neuronal Loss Is Greater in the Locus Coeruleus Than Nucleus Basalis and Substantia Nigra in Alzheimer and Parkinson Diseases. Arch Neurol. 2003;60(3):337-341. doi:10.1001/archneur.60.3.337 [doi]
11. Pasquini J, Sigurdsson HP, Firbank M, Best L, Foster V, Galley D, Maxwell R, Silani V, Ceravolo R, Petrides G, Brooks DJ, Pavese N. Locus coeruleus neuromelanin, cognitive dysfunction, and brain metabolism in multiple system atrophy. J Neurol. 2025 Feb 11;272(3):195. doi: 10.1007/s00415-025-12932-5. PMID: 39932591; PMCID: PMC11814031. [doi] [pmid]
12. Jost, W.H., Rau, A., Brumberg, J. et al. Neuroimaging in multiple system atrophy: clinical implications and novel developments. J Neural Transm (2025). https://doi.org/10.1007/s00702-025-02921-3 [doi]
13. Madelung CF, Meder D, Fuglsang SA, Marques MM, Boer VO, Madsen KH, Petersen ET, Hejl AM, Løkkegaard A, Siebner HR. Locus Coeruleus Shows a Spatial Pattern of Structural Disintegration in Parkinson's Disease. Mov Disord. 2022 Mar;37(3):479-489. doi: 10.1002/mds.28945. Epub 2022 Feb 3. PMID: 35114035; PMCID: PMC9303353. [doi] [pmid]
14. Betts MJ, Kirilina E, Otaduy MCG, Ivanov D, Acosta-Cabronero J, Callaghan MF, Lambert C, Cardenas-Blanco A, Pine K, Passamonti L, Loane C, Keuken MC, Trujillo P, Lüsebrink F, Mattern H, Liu KY, Priovoulos N, Fliessbach K, Dahl MJ, Maaß A, Madelung CF, Meder D, Ehrenberg AJ, Speck O, Weiskopf N, Dolan R, Inglis B, Tosun D, Morawski M, Zucca FA, Siebner HR, Mather M, Uludag K, Heinsen H, Poser BA, Howard R, Zecca L, Rowe JB, Grinberg LT, Jacobs HIL, Düzel E, Hämmerer D. Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases. Brain. 2019 Sep 1;142(9):2558-2571. doi: 10.1093/brain/awz193. PMID: 31327002; PMCID: PMC6736046. [doi] [pmid]
Cite this abstract
http://echo.ismrm.org/p/ISMRM2026/563-01-011